lundi 1 octobre 2018

Onco Actu du 1er octobre 2018

2.11 Etiologie - Alimentation

More Evidence That Nutrition Studies Don’t Always Add Up [NY Times]

4.10 Dép., diag. & prono. - FDA, EMA, NICE,...

FDA authorizes first next generation sequencing-based test to detect very low levels of remaining cancer cells in patients with acute lymphoblastic leukemia or multiple myeloma [FDA]

5.10 Traitements - Essais

Clinical Trials: FDA Releases Two Draft Guidances [RAPS]

5.12 Immunothérapies

A Patient-partnered Genomics Study Identifies Immunotherapy as Potential Treatment for a Rare Cancer [AACR]

Cancer Immunotherapy Conference in New York City Features Latest Research on Response, Resistance, New Approaches to Treatment [AACR]

5.12.2 Immunothérapies - CAR-T, thérapies cellulaires

Loyola is working on a new and improved CAR-T product, looking to overcome high-frequency side effects [EndPoints]

5.12.6 Immunothérapies - AMM

FDA approves Libtayo® (cemiplimab-rwlc) as first and only treatment for advanced cutaneous squamous cell carcinoma [Sanofi]

FDA approves first treatment for advanced form of the second most common skin cancer [FDA]

A speedy FDA offers lightning review and quick OK for the latest PD-1 from Regeneron and Sanofi [EndPoints]

5.12.7 Immunothérapies - vaccins

New Cancer Vaccine Shows Early Promise for Patients with HER2-positive Cancers Bacterial Therapy Tolerable, Shows Early Promise in Patients With Advanced Solid Tumors [AACR]

5.3.4 Traitements - AMM (FDA, EMA,...)

Pfizer's once-failed Vizimpro rebounds with targeted lung cancer approval [FiercePharma]

6. Lutte contre les cancers

Tired of male-dominated meetings, leading cancer conference makes nearly all of its speakers women [Science]

6.12 Ethique

Sloan Kettering Executive Turns Over Windfall Stake in Biotech Start-Up [NY Times]

A Message to All Employees [MSK]

6.14 Prix Nobel

2018 Nobel Prize in Physiology or Medicine jointly to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation [Nobel Prize]

6.5 Médecines alternatives/complémentaires

The Risk of Alternative Cancer Treatments [NY Times]

6.8 Communication

Serena Williams covers Divinyls hit for breast cancer awareness [The Guardian]

6.9 Controverses

Cochrane ousted researcher over improper use of letterhead, board co-chair says [STAT]